All data are based on the daily closing price as of July 17, 2024
s

Sam Chun Dang Pharm

000250.KQ
137.17 USD
-3.90
-2.76%

Overview

Last close
137.17 usd
Market cap
2.94B usd
52 week high
154.60 usd
52 week low
36.56 usd
Target price
45 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
11.4698
Price/Book Value
10.0221
Enterprise Value
1.58B usd
EV/Revenue
11.2667
EV/EBITDA
336.0815

Key financials

Revenue TTM
128.11M usd
Gross Profit TTM
60.12M usd
EBITDA TTM
12.87M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
307.14M usd
Net debt
N/A usd

About

Sam Chun Dang Pharm. Co., Ltd manufactures, distributes, imports, and exports pharmaceuticals in South Korea. It provides ophthalmology, cardiovascular, endocrinology, antibacterial, anti-fungal, antiviral, respiratory, anti-inflammatory, antihistamine, and musculoskeletal products, as well as vitamins and gastro intestine products. The company was founded in 1943 and is headquartered in Seoul, South Korea.
  • Symbol
    000250.KQ
  • Exchange
    KQ
  • Isin
    KR7000250001
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Pharmaceuticals
  • CEO
    Dae-In Yoon
  • Headquarter
    Seoul
  • Web site
    https://www.scd.co.kr

Related news

Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top